Chronic Myeloid Leukemia: A Comprehensive Guide
Medically reviewed by Andre Stone | MD, University of Pittsburgh School of Medicine on April 1st, 2026.
Published on April 1st, 2026. Updated on August 25th, 2026.
Key Takeaways
Chronic myeloid leukemia (CML) is a slow-growing blood cancer affecting white blood cells in bone marrow
The Philadelphia chromosome, found in 95% of cases, drives abnormal cell growth and is key to diagnosis
Early symptoms include fatigue, weight loss, and enlarged spleen, but many people have no symptoms initially
Targeted therapy drugs called tyrosine kinase inhibitors have transformed CML treatment with excellent outcomes
With effective treatment and regular monitoring, many people with CML can have a near-normal life expectancy and maintain a good quality of life, although outcomes vary.
Overview
Chronic myeloid leukemia (CML) is a type of blood cancer that starts in the bone marrow. It affects the cells that make white blood cells, causing them to grow and multiply abnormally. Unlike acute leukemias that progress rapidly, CML develops slowly over months or years.
CML accounts for about 10-15% of all leukemia cases in adults. CML mainly affects older adults, although it can occur at any age and is uncommon in children. Men are slightly more likely to develop CML than women.
The condition begins when bone marrow cells acquire a specific genetic change called the Philadelphia chromosome. This abnormal chromosome creates a protein that tells cells to keep dividing when they should stop. Over time, these abnormal cells crowd out healthy blood cells, leading to various health problems if left untreated.
A routine blood test may first suggest CML, sometimes before symptoms develop. Additional genetic or molecular testing is needed to confirm the diagnosis and guide treatment. Many people now live for decades with CML when they take their medicine regularly and see their doctor for checkups.
Symptoms & Signs
CML often develops gradually, and many people have no symptoms in the early stages. When symptoms do appear, they're usually related to having too many abnormal white blood cells or not enough healthy blood cells. Some people learn they have CML only when a routine blood test shows unusual results.
Primary Symptoms
Fatigue and weakness - Low red blood cell counts cause persistent tiredness and shortness of breath
Unexplained weight loss - Loss of appetite and unintentional weight loss over several weeks or months
Enlarged spleen - Abdominal fullness, pain under left ribs, or feeling full quickly when eating
Easy bruising or bleeding - Small red spots on skin, nosebleeds, or bleeding gums from low platelet counts
Frequent infections - Recurring illnesses due to abnormal white blood cell function
Night sweats - Excessive sweating during sleep without obvious cause
Bone or joint pain - Aching discomfort, especially in ribs, spine, or pelvis
Symptoms can vary widely from person to person. Some people feel only mild tiredness for months before getting diagnosed. Others experience multiple symptoms that make them feel quite sick and prompt them to see a doctor sooner.
When to Seek Care
Contact your healthcare provider if you experience persistent fatigue lasting more than two weeks, unexplained weight loss, or pain under your left ribs. See a doctor promptly if you have unusual bleeding that doesn't stop, frequent infections, or severe abdominal pain.
Don't wait if you notice several symptoms happening together. Even if you're not sure what's causing them, it's important to get checked out by a medical professional.
When to Seek Immediate Care
Get emergency medical attention for severe bleeding that won't stop, signs of serious infection like high fever or difficulty breathing, or severe abdominal pain with nausea and vomiting.
Causes & Risk Factors
Age
Risk Factors and Causes
CML is most common between ages 45 and 65 and is rare in children and young adults. It is slightly more common in men than in women. CML is not inherited; it results from genetic changes acquired in bone marrow cells. High-dose ionizing radiation exposure is a recognized but uncommon risk factor, and most people diagnosed with CML have no identifiable cause.
Genetics
Not inherited, but involves acquired genetic changes in bone marrow cells
Radiation
High-dose ionizing radiation exposure is a recognized but uncommon risk factor. CML after cancer treatment is uncommon, and most people diagnosed with CML have no identifiable cause.
Gender
Slightly more common in men than women
Previous Treatment
High-dose ionizing radiation is a recognized but uncommon risk factor. CML after cancer treatment is uncommon, and most people diagnosed with CML have no identifiable cause.
Continue Learning
How CML Is Diagnosed
Diagnosis
Medical History & Physical Examination
Your doctor will ask about symptoms like fatigue, weight loss, and any abdominal discomfort. They'll want to know about your medical history, including any radiation exposure or previous cancer treatments. The physical exam focuses on checking for enlarged organs, especially the spleen and liver, which can be felt during abdominal examination.
During the exam, your doctor will also check for swollen lymph nodes, signs of bleeding or bruising, and overall appearance. They may also listen to your heart and lungs and consider other conditions that can cause similar symptoms, such as fatigue.
Diagnostic Testing
Complete blood count (CBC) - Checks numbers of white blood cells, red blood cells, and platelets to identify abnormal counts
Blood smear examination - Looks at blood cells under microscope to identify abnormal cell shapes and maturity levels
Bone marrow biopsy - Takes sample from hip bone to examine cell types and confirm diagnosis
Cytogenetic testing - Identifies Philadelphia chromosome and other genetic changes in cancer cells
Molecular testing - Measures BCR::ABL1 genetic material in blood or bone marrow to confirm the diagnosis and monitor treatment response
Get Chronic Care Relief Today
Learn More
Treatment Options
The goal of CML treatment is to eliminate or significantly reduce abnormal cells while maintaining quality of life. Treatment focuses on targeting the specific protein that drives CML growth. Most people need to take medication for many years or for life to keep the disease under control.
Conservative Treatments
Tyrosine kinase inhibitors (TKIs) - Oral medications like imatinib that specifically block the abnormal protein causing CML
Regular monitoring - Blood counts and molecular blood tests track treatment response; bone marrow testing is used at diagnosis and in selected situations
Supportive care - Management of side effects, infections, and other complications during treatment
Hydroxyurea - Temporary medication to quickly reduce high white blood cell counts before starting targeted therapy
Most people start with a TKI pill taken by mouth once or twice daily. These medicines are generally easier to tolerate than traditional chemotherapy, but they can cause important side effects that vary by drug and require regular monitoring. Many people can maintain a good quality of life during treatment. Your doctor will check your blood regularly to make sure the medicine is working well.
Advanced Treatments
Other TKIs - Drugs such as dasatinib or nilotinib may be used as initial treatment or when another TKI is ineffective, causes unacceptable side effects, or is unsuitable for a particular patient
Stem cell transplant - A potentially curative treatment considered for advanced disease, resistance or intolerance to available medicines, or other high-risk situations; eligibility depends on overall health, disease status, donor options, and age
Clinical trials - Access to experimental treatments and newer targeted therapies under development
Some patients may need to switch medicines if their first one stops working. Doctors have several other drugs available that work in different ways. For a small number of people, a stem cell transplant offers the best chance for a cure, though this is a serious procedure requiring careful consideration.
Living with the Condition
Daily Management Strategies
Take medications exactly as prescribed, even if you feel well, since CML treatment requires consistent daily therapy. Keep a medication schedule and use pill organizers to avoid missing doses. Stay hydrated and eat a balanced diet to support your immune system. Regular exercise, as tolerated, can help maintain energy levels and overall health. Maintaining consistent daily routines can support better treatment adherence and outcomes.
Many people find it helpful to set phone alarms or use pill reminder apps to remember their medicine. Keeping a journal of symptoms and side effects can help your doctor manage your treatment. Blood counts and molecular tests are needed to determine how well the CML is responding. Don't be shy about telling your doctor about side effects or problems taking your medicine.
Exercise & Movement
Most people with well-controlled CML can participate in regular physical activity. Start slowly with walking, swimming, or gentle yoga if you're feeling fatigued. Avoid contact sports that could increase bleeding risk, especially if platelet counts are low. Listen to your body and rest when needed, gradually building activity as energy improves with treatment.
Staying active helps fight fatigue and keeps your body strong. Even short walks around your home count and can make you feel better. Talk to your doctor before starting a new exercise program to make sure it's safe for you.
Prevention
Limit radiation exposure - Avoid unnecessary medical imaging with radiation and follow safety guidelines if working with radioactive materials
Follow general health screening guidelines - Regular checkups may occasionally detect abnormal blood counts.
Maintain overall health - Eat a balanced diet, exercise regularly, and don't smoke to support immune system function
Share your family medical history with your healthcare team as part of routine care. CML is not inherited, and family history does not usually lead to CML screening.
Since the cause of CML is unknown for most people, there's no guaranteed way to prevent it. A healthy lifestyle supports general well-being but has not been shown to prevent CML. Routine checkups may occasionally identify abnormal blood counts, but there is no recommended screening test for CML in people without symptoms or abnormal results.
Frequently Asked Questions
While CML is rarely cured completely, modern targeted therapies allow most people to achieve deep remission and live normal lifespans. Many patients maintain BCR::ABL1 levels below the test's detection limit for years with treatment.
With current treatments, most people with CML have near-normal life expectancy. Studies show 10-year survival rates above 90% for those who respond well to targeted therapy.
Many people continue working during CML treatment, especially once initial symptoms improve. Fatigue may require schedule adjustments, and some people need time off for medical appointments and side effect management.
Most CML patients don't need traditional chemotherapy. Targeted therapy pills are the standard first-line treatment and are much easier to tolerate than conventional chemotherapy.
CML can return if treatment is stopped or if cells develop resistance to medication. Regular monitoring remains essential. Most people continue treatment, but carefully selected patients with a sustained deep molecular response may try stopping therapy under close specialist supervision because relapse can occur and requires prompt detection.
Still have questions?
Consult with a healthcare professional for personalized advice.